Abstract Background. Congenital pelvi-ureteric junction obstruction (PUJO) affects 0.3% of human births. It may result from aberrant smooth muscle development in the renal pelvis, resulting in hydronephrosis. Mice that are null mutant for the Teashirt3 (Tshz3) gene exhibit congenital PUJO with defective smooth muscle differentiation and absent peristalsis in the proximal ureter. Methods. Given the phenotype of Tshz3 mutant mice, we considered that Teashirt genes, which code for a family of transcription factors, might represent candidate genes for human PUJO. To evaluate this possibility, we used in situ hydridization to analyse the three mammalian Tshz genes in mouse embryonic ureters and determined whether TSHZ3 was expressed in the human embryonic ureter. TSHZ2 and TSHZ3 were sequenced in index cases with non-syndromic PUJO.
Results. Tshz2 and Tshz3 genes were detected in mouse ureters and TSHZ3 was expressed in the human embryonic renal pelvis. Direct sequencing of TSHZ2 and TSHZ3 did not identify any mutations in an initial cohort of 48 PUJO index cases, excluding these genes as a major cause of this condition. A polymorphic missense change (E469G) in TSHZ3 was identified at a residue highly conserved throughout evolution in all Teashirt proteins, although subsequently no significant difference between the E469G allele frequency in Albanian and Macedonian PUJO index cases (3.2%) versus 633 control individuals (1.7%) was found (P = 0.18).
Conclusions. Mutations in TSHZ2
and TSHZ3 are not a major cause of PUJO, at least in Albanian and Macedonian populations. Expression of these genes in the human fetal ureter emphasizes the importance of analysing these genes in other groups of patients with renal tract malformations.
Introduction
Congenital pelvi-ureteric junction obstruction (PUJO) occurs in 0.3% of human births and is usually diagnosed by postnatal investigations prompted by detecting fetal hydonephrosis on ultrasound screening [1] [2] [3] . PUJO can be associated with impaired kidney excretory function in which case surgery to refashion the PUJ may be undertaken [4, 5] . Congenital unilateral PUJO occasionally occurs in association with a contralateral, more severe anomaly such as multicystic dysplastic kidney [6] , so PUJO may represent the mild end of a malformation spectrum with aberrant morphogenesis of the ureter and renal pelvis. PUJO can occur in more than one member of the same family [7] [8] [9] [10] , so it may have a genetic basis, at least in certain cases. In some kindreds, there appears to be a dominant inheritance pattern, and Izquierdo [10] provided data to support linkage to chromosome 6p. In other families, however, PUJO is not linked to this locus [9, 11] , suggesting genetic heterogeneity. PUJO is a heterogeneous condition at the anatomical level, sometimes being associated with intrinsic defects of the ureteric wall, discussed below, while in other cases a 'crossing vessel' causes external compression [7] . Antonakopoulos et al. [12] reported abnormal smooth muscle (SM) arrangements at the junction of the proximal ureter and renal pelvis in resected PUJs; the normal interwoven pattern was absent and instead SM bundles were arranged in 'an outer circular and an inner longitudinal layer'. dell'Agnola et al. [13] reported that both time between fetal diagnosis and PUJ resection and the size of the hydronephrosis were 'related to the frequency of muscle hypertrophy and fibrosis of both pelvis and ureter just above and below the junction'. Murakumo et al. [14] examined PUJO specimens with 'intrinsic obstruction' and noted that 'muscle fascicles were sparse and thin'. Another study [15] reported that resected PUJs were 'inflamed and markedly thickened due to a combination of muscle hypertrophy and fibrosis around muscle fibres'. While some of these aberrations are probably disruptions caused by excessive distension and/or superimposed infection, the observations also give rise to the hypothesis that at least some cases of congenital PUJO are caused by primary defects of SM differentiation and morphogenesis.
There are three mammalian Teashirt (Tshz) genes and they code for a family of transcription factors, with homologues first described in flies where they modulate anteriorposterior embryonic patterning and tissue morphogenesis [16] [17] [18] . In mice, Tshz3 is expressed in mesenchymal cells that form the wall of the embryonic ureter, and Tshz3 function is required for upregulation of myocardin [19] , a molecule involved in the transcriptional machinery that directs the expression of SM contractile proteins [20] . Mice with null mutation of Tshz3 do not form SM cells in the proximal ureter [19] . On a CD1 background, homozygous mutant mice invariably have bilateral fetal hydonephrosis, whereas a subset of animals with just one mutant allele have unilateral hydronephrosis [19] . Although these ureters Table 1 . PCR primers used for PCR amplification of TSHZ2 and TSHZ3
Primer
Sequence (5 to 3 )
TTTCTCCTTGTCGACTTCCTTCTGGGCC a 60 • C annealing temperature was used for all TSHZ3 primers and for E469Gdig; a 66 • C annealing temperature was used for all TSHZ2 primers. a Mismatches incorporated to engineer a diagnostic restriction site are underlined and in bold.
are not anatomically blocked, urine flow is impaired because of functional obstruction caused by absent peristalsis in the proximal ureter [19] . Aspects of the mouse phenotype, with SM pathology and congenital hydronephrosis, are reminiscent of human PUJO. Therefore, the possibility that TSHZ genes may be implicated in human PUJO represents a hypothesis worthy of serious study. To this end, in the current paper, we first ascertained whether the other two Teashirt gene family members (i.e. Tshz1 and Thsz2) are also expressed during formation of the mouse ureter. We then went on to determine whether humans with congenital PUJO might have mutations of either TSHZ2 or TSHZ3, the two members of the gene family expressed in fetal ureters.
Patients and methods

In situ hybridization (ISH)
ISH using digoxigenin-labelled or radioactive probes was performed on sections as described [18] . For ISH of human embryos, a 997 bp TSHZ3 DNA fragment was generated by PCR with primers HTSHZ3-F and HTSHZ3-R ( Table 1 ). The PCR product was cloned into pGEM-T Easy vector (Promega), and sense and antisense probes were generated with S 35 UTP. Slides were exposed for 7 days at 4 • C under desiccant. The human fetal renal tract to be analysed by ISH was obtained from the MRC-Wellcome Trust Human Developmental Biology Resource (http://www.hdbr.org/) as described [21, 22] .
Patients
Index cases with congenital PUJO (one each from 49 families) were ascertained by two of the authors (V. T. and Z. G.) in their clinics in Macedonia. All these individuals had presented hydronephrosis visualized on antenatal ultrasound screening. Postnatally, the specific diagnosis was confirmed using appropriate imaging, including ultrasonography to demonstrate persistent hydronephrosis and the exclusion of vesicoureteric reflux as a cause for renal tract dilatation. One case had neurofibromatosis type 1 and she was excluded from further analysis because this condition can itself be associated with renal tract anomalies [23] . Another case had distal renal tubular acidosis type 1 as well as PUJO but was retained in the current analysis. Therefore, no index case included in our primary genetic analyses had features of a recognizable, multi-organ syndrome and they were thus typical of PUJO cases presenting to Paediatric Nephrology and Urology clinics. Note that relatives of index cases had not been systematically screened to detect renal tract anomalies; however, in a few families, siblings were known to be affected (e.g. see Results section). Of these 48 index cases, 21 were of Macedonian origin, 22 were of Albanian origin, 2 were of Turkish origin, 2 were of Gypsy descent and 1 was of Bosnian origin. Subsequently, the THSZ3 gene variant E469G was analysed in an additional 19 non-syndromic PUJO index cases (11 of Macedonian, 7 of Albanian and 1 of Gypsy descent) when DNA became available. As in other clinical studies of PUJO (e.g. 24), our cohort of 67 cases was mostly male (χ 2 test, P = 0.0003), and PUJO was predominantly unilateral (Table 2) . In these males, there was a significant skewing towards left-sided PUJO in unilateral cases (χ 2 test, P = 0.0012).
Sequencing of human genomic DNA Consent was obtained for collection of blood to be used for DNA extraction from leucocytes. TSHZ2 and TSHZ3 (Ensembl accession numbers OT-THUMG00000033058 and OTTHUMG00000071116, respectively) exons were amplified in standard PCR reactions from human leucocyte DNA with primers listed in Table 1 . Following treatment (37 • C for 30 min followed by 85 • C for 15 min) with Exonuclease I (10 U; NEB) and shrimp alkaline phosphatase (2 U; Roche), PCR products were sequenced using the Big Dye Terminator kit (Applied Biosystems). To rapidly detect the THSZ3 E469G variant, we used a diagnostic restriction digest (ApaI (+)) with primers E469GdigF and E469GdigR (Table 1) .
Results
Gene expression in developing ureters
In embryonic mice, SM precursor cells in the wall of the proximal ureter upregulate expression of contractile proteins from embryonic day (E) 15 [19] , equivalent to the end of the first third of human gestation [25] . Using ISH (Fig- ure 1A-I), we found that expression of both Tshz2 and Tshz3 preceded this differentiation event because transcripts were present in mesenchymal cells in proximal ureters at E14; these patterns were also observed one day later. By contrast, no specific ureteric ISH signal for Tshz1 could be detected in the proximal ureter. We detected expression of TSHZ3 in peri-urothelial cells of the proximal ureter and renal pelvis in a human embryo at 9 weeks of gestation ( Figure 1J and K).
TSHZ genomic analyses
We sequenced the complete coding regions of TSHZ2 and TSHZ3 in the 48 PUJO index cases initially available to us. As well as three known single nucleotide polymorphisms (SNPs), we identified five variants, one in TSHZ2 and four in TSHZ3 (Table 3) , previously unreported in the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/ SNP/). Four variants were silent (i.e. would not be predicted to alter the encoded protein), suggesting that they were unlikely to be pathogenic. The other was a 1406A>G transition in TSHZ3 coding for an E469G missense change in which glutamic acid, a negatively charged and hydrophilic molecule, is changed to glycine, a nonpolar and hydrophobic residue. This substitution was found to be heterozygous in four index cases and homozygous in other one (Tables 3  and 4 ; Figure 2 ). This variant alters an amino acid conserved as a charged residue in all three Teashirt proteins residing in a highly evolutionarily conserved stretch of amino acids ( Figure 2B ). We next used an ApaI(+) diagnostic restriction digest to confirm the genotypes in the original 48 patients and to genotype an additional 19 PUJO index cases collected since our study initiated. We also sought the variant in control DNA samples from individuals of Albanian, Macedonian and Turkish descendants and additionally in UK Caucasian controls. Although the E469G allele frequency in Albanian PUJO patients (3 heterozygous individuals) was almost double that observed in 37 Albanian control individuals (5.0% versus 2.7%), the difference was not significant (P = 0.40). There was no difference in the allele frequency between the one heterozygous Macedonian PUJO index case and 275 Macedonian control individuals (1.6% versus 2.0%; P = 0.73). Neither the Bosnian nor the two Gypsy PUJO index cases carried the variant allele. One of the two Turkish PUJO index cases, a female, was homozygous for the E469G allele. Considering the frequency of this allele in a Turkish control population (5.45%), the observation of a homozygote does not conform to Hardy-Weinberg equilibrium. This, together with the fact that the frequency of the E469G allele in 37 Turkish control individuals was elevated in comparison to all other control groups combined (5.54% versus 1.7%; P = 0.045), led us to exclude the Turkish patients from further statistical comparisons to avoid population stratification effects. We found that the frequency of the E469G allele did not differ significantly between Albanian, Macedonian and the 321 UK Caucasian control individuals (Table 4) and so, to maximize our statistical power, we performed a combined analysis comparing the allele frequency in 62 Albanian and Macedonian PUJO index cases versus all 633 Albanian, Macedonian and UK Caucasian controls. There was no evidence for an elevated frequency of the E469G allele in the disease group (P = 0.18), suggesting that the E469G variant is not a risk factor for PUJO in Albanian and Macedonian populations. Figure 2C depicts the family of Turkish descent, in which the index PUJO case was homozygous for the E469G variant. Interestingly, it had been found that her two heterozygous siblings each had unilateral small kidney (i.e. presumed renal hypoplasia), with an overtly normal contralateral renal tract. Given the E469G allele frequency in Turkish controls, the difference in the proportion of homozygotes between Turkish cases (1/2) and controls (0/37) is significant (P = 0.05; Fisher exact test). If we assume, in the most conservative scenario, that the homozygous father is the product of a first-cousin marriage, the correct segregation of the E469G allele in the three siblings (assuming a semi-dominant disease model) would only be expected with a frequency of 2.8 per 1000 by chance. However, the fact that the unaffected father was also homozygous makes it unclear whether this variant is related to disease.
Discussion
This study shows that Tshz3 transcripts are expressed in the proximal part of the embryonic ureter, both directly before (E14) and at the onset (E15) of muscularization [19, 26] . This finding was to be expected, given the fact that the protein encoded by this gene is known to be present in these locations during mouse embryogenesis [19] . The fact that we also detect TSHZ3 transcripts in the human embryonic ureter can be taken as evidence that gene function in ureter SM formation might be conserved between mouse and man. We also report the novel observations that Tshz2 but not Tshz1 is expressed in the differentiating ureter, as assessed by ISH. By contrast, the same methodology has detected Tshz1 expression in other parts of the embryo [27] , thus excluding a negative finding due to technical error.
Whether an individual is born with a urinary tract malformation is most likely determined by a complex interplay between genes and environmental factors rather than because of mutation in a single 'PUJO gene'. Indeed, only a subset of Tshz3 +/− mutant mice on an outbred background have congenital hydronephrosis [19] . Moreover, the fact that congenital human PUJO, as in the current series, is predominantly unilateral similarly suggests a complex causation. Previously, variants of other genes expressed in the urinary tract have been implicated in the pathogenesis of urinary tract anomalies. These genes include AT2, RET, ROBO2 and UPK2 and 3 [21, 22, [28] [29] [30] [31] [32] , variously implicated in duplicated renal tract, vesicoureteric reflux and other phenotypes. Furthermore, reports of unaffected mutation carriers in affected families show that these variants are incompletely penetrant, and this is frequently manifested as unilateral disease.
Collectively, the expression data presented in this paper were consistent with TSHZ2 (chromosome 20q13.2) and TSHZ3 (19q13.11) as candidate genes for congenital PUJO. To our knowledge, before the current study, neither gene has been analysed in humans with congenital disease. Overall, our results suggest that mutations in these two genes do not play a major role in the pathogenesis of human PUJO. We failed to find any variants of TSHZ2 that would be of functional significance. We did, however, identify a non-synonymous allele of TSHZ3 at a residue that shows extensive evolutionary conservation across Teashirt proteins. Indeed, the E469 variant forms part of a motif, VEVKKEV, that may regulate sumoylation of TSHZ3; the amino acids YKXE represent a core sumoylation motif, and K472 is predicted to undergo sumoylation using the web-based tool, SUMOsp 2.0 (http://bioinformatics.lcdustc.org/gps2). Sumoylation, a protein degradation pathway, is known to regulate transcription by modifying the DNA-binding activity of transcription factors and their subcellular localization and interactions between transcription factors and their co-regulators [33] . This suggested that the E469G substitution would affect the function of the encoded protein.
To investigate whether this variant contributes to disease, we extensively analysed its frequency in several populations, but found no evidence for the association of the E469G variant with human PUJO. It remains possible, however, that this variant could contribute to disease in other groups of patients with urinary tract malformations, and this warrants future investigation. Our characterization of the genetic variation at the TSHZ2 and TSHZ3 loci, and especially our identification of particular haplotypes segregating with the E469G TSHZ3 variant ( Figure 2C ), offers valuable information for future association studies.
Our current analysis was limited to direct sequencing of TSHZ2 and TSHZ3 coding regions, and so this study does not exclude heterozygous deletions or mutations in regulatory elements. It will therefore be necessary to analyse patients with PUJO for copy number variations using methods such as array-based comparative genomic hybridization or multiplex ligation-dependent probe amplification. Interestingly, translocations and a chromosomal deletion disrupting the 19q12 region in which TSHZ3 resides have also been reported in patients with multi-organ malformations, with renal tracts affected by hydonephrosis and multicystic dysplastic kidney [34, 35] , implicating the disruption of long-range elements in regulating the expression of TSHZ3. Therefore, it may be informative to seek mutations in conserved non-coding elements of TSHZ3 in patients because mutations in cis-regulatory elements have been shown to cause human disease [36] and the Tshz family is known to have a large number of such duplicated elements [37] . We suggest that it may also be worthwhile to screen patients with urinary tract malformations other than PUJO (such as multicystic dysplastic kidney) for TSHZ mutations. As well as hydronephrosis, Tshz3 null-mutant mice exhibit respiratory problems at birth [19] that may reflect a function of the Tshz3 gene in the brain stem and/or lungs where it is expressed (unpublished data). It is therefore possible that humans with major TSHZ3 mutations may not survive the neonatal period, thus explaining why mutations are not found in non-syndromic survivors with PUJO.
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